![]() |
市場調查報告書
商品編碼
2016762
植入式醫療設備市場規模、佔有率、趨勢和預測:按類型、最終用途和地區分類,2026-2034年Implantable Medical Devices Market Size, Share, Trends and Forecast by Type, End Use Sector, and Region, 2026-2034 |
||||||
2025年,全球植入式醫療設備市場規模達1,476億美元。展望未來,IMARC Group預測,該市場從2026年到2034年將以4.27%的複合年成長率成長,到2034年達到2175億美元。慢性病盛行率上升、對更小巧、更先進的植入式醫療設備的需求不斷成長,以及數位健康技術和連網功能在植入式醫療器材中的日益融合,是推動市場成長的主要因素。
醫療植入是用於替代或作為特定身體部位或整個生物結構一部分的醫療設備。每年,成千上萬的人透過植入或取出植入式醫療設備的手術來改善生活品質。目前,植入被用於身體的各個部位,發揮多種功能,包括整形外科、心臟節律器、心血管支架、去心房顫動、義肢和藥物輸送系統。植入透過外科手術或藥物方法完全或部分植入人體。根據需要,器械可以永久或暫時植入,並在日後取出。隨著人們壽命的延長,與老齡化相關的疾病數量也在增加。這進一步增加了對各種維持生命的醫療設備的需求,包括新的治療方法、植入、義肢和長期用藥。植入式醫療設備由多種材料製成,包括組織、金屬、骨骼、塑膠、皮膚和陶瓷。
受消費者對自身外表日益關注的推動,整容手術越來越普遍,進而帶動了對植入式醫療設備的需求。此外,人工植牙、胸大肌植入、三角肌植入、大腿增大、乳房植入和人工電子耳等提升個人美感的技術創新,也進一步刺激了這些器械的需求成長。同時,需要植入各種植入來維持患者生命的慢性疾病(例如心臟衰竭、關節炎以及運動、感覺和認知功能障礙)的發病率不斷上升,也對市場成長產生了積極影響。此外,已開發國家和發展中國家人口老化加劇,導致各種慢性疾病的盛行率上升,進一步推動了對這些產品的需求。
The global implantable medical devices market size reached USD 147.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 217.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.27% during 2026-2034. The rising prevalence of chronic diseases, increasing demand for smaller, more advanced implantable medical devices, and growing integration of digital health technologies and connectivity features in implantable devices are some of the key factors driving the growth of the market.
Medical implants are devices that are used to replace or act as a fraction for a particular body part or for the whole biological structure. Every year thousands of people enhance the quality of their lives by going through surgical procedures that involve the fixing or removal of implantable medical devices. At present, implants are used for various parts of the body for different functions such as orthopedics, pacemakers, cardiovascular stents, defibrillators, neural prosthetics or drug delivery system. Implants are introduced either completely or partially via surgical or medical methods into the human body. The device can be implanted permanently or temporarily, depending upon the need and can be removed later on. There has been an increase in the number of age-related diseases with concurrent rise in the life-span of people. This has further increased the demand of various life prolonging medical aids such as new treatments, implants, prostheses, and long-term pharmaceutical usage. Implantable devices are made up of various types of materials such as tissues, metals, bones, plastics, skin, ceramics, etc.
Catalyzed by a strong growth of consumers' inclination towards body aesthetics and physical appearance, cosmetic surgeries are becoming increasingly common, driving the demand of implantable medical devices. Moreover, advancing technological innovations that enable an individual to enhance his/her beauty such as dental implants, pectoral implants, deltoid implants, thigh augmentation, breast implants, cochlear implants, etc. have further added to the rising demand of these devices. Additionally, rising occurrence of chronic diseases such as heart failures, arthritis, motor, sensory or cognitive modality, etc. that require various types of implants to sustain the life of a patient are also creating a positive impact on the growth of the market. Moreover, an increase in the geriatric population across both developed and developing regions has resulted in a rising prevalence of various chronic diseases which is further propelling the demand of these products.
The publisher provides an analysis of the key trends in each segment of the global implantable medical devices market report, along with forecasts at the global and regional levels from 2026-2034. Our report has categorized the market based on product type, material and end-user.
Based on the product type, the market has been segmented into orthopedic implants, dental implants, facial implants, breast implants, cardiovascular implants, and others.
Based on the material, the market has been segmented into polymers, metals, ceramics and biologics.
Based on the end-user, the market has been segmented into hospitals, ambulatory surgery centers and clinics.
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. North America currently represents the largest market.
The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Conmed Corporation, Globus Medical, Inc., Integra Lifesciences Holdings Corporation, Johnson & Johnson, LivaNova PLC, Medtronic plc, Nuvasive, Inc., Smith & Nephew Plc, St. Jude Medical, Inc., Institut Straumann AG., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet Holdings, Inc.
This report provides a deep insight into the global implantable medical devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the implantable medical devices industry in any manner.